‘My cancer was not in those pictures’: how breast density affects mammograms
A new FDA rule requires that screenings inform people if they have a high ratio of dense breast tissue. Experts say it’s just one step toward awarenessIn 2017, 55-year-old Leslie Ferris Yerger underwent a routine mammogram and breast ultrasound. Both came back clear. Two months later, she had an unrelated Dexa scan to measure her bone density. The technician noticed an abnormality in her hip. After additional testing, Yerger was diagnosed with stage four breast cancer – an advanced stage of the disease in which the cancer has spread beyond the breasts.The mammogram and ultrasound had not picked up the cancer because, Yerger would learn, of her dense breast tissue. Continue reading…
Let’s Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
(MedPage Today) — As an FDA-mandated rule goes into effect requiring healthcare providers to notify women of their breast density, the American Cancer Society has an explainer on what the rule means for patients and providers.
Analysis of another…
Shop these pink products that support breast cancer charities
From the Estée Lauder Bouquet of Strength collection to Pretty in Pink PJs, lifestyle expert Chassie Post joins TODAY with a list of businesses that are giving back to breast cancer charities!
Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
Kathy Bates addresses Ozempic rumors after 100-pound weight loss: ‘This was hard work’
Kathy Bates credited both hard work and Ozempic medication for her diabetes diagnosis for helping her lose 100 pounds over a span of seven years.
STAT+: Medicare already covers GLP-1s for half of seniors with obesity, new report finds
Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.
Ozempic underworld: Inside the black market of obesity drugs
A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).Read more…
Combination therapeutic strategy identified for triple negative breast cancer
Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women’s Hospital are pointing the way toward therapeutic strategies that could be tested in clinical trials in the future.
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know
A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, have become widely known for their slimming side effects.Read more…